Smith & Nephew Awarded Contract to Provide Negative Pressure Wound Therapy Systems to the DoD
By Azmed Devices Editorial Team
Smith & Nephew has been selected to provide its RENASYS TOUCH Negative Pressure Wound Therapy Systems to the U.S. Department of Defense under a 10-year contract valued at up to $75 million.
Smith & Nephew, a global medical technology company, has secured a significant 10-year contract to supply its RENASYS TOUCH Negative Pressure Wound Therapy systems to the United States Department of Defense. This agreement, facilitated through the Defense Logistics Agency, carries a potential value of up to $75 million. The company aims to support military medical providers by offering a versatile and portable solution for managing wounds across various challenging environments, including surgical interventions, aeromedical transport, and definitive care within military treatment facilities. Notably, the firm manufactures these specific systems within the United States.
The RENASYS TOUCH system offers military personnel clinical efficacy and operational flexibility through features such as an intuitive interface and adjustable therapy modes. According to the company, these capabilities are essential for individualized patient care in austere settings. By providing simplified wound therapy, Smith & Nephew seeks to assist war fighters throughout the military care continuum. The company emphasizes that the design of the equipment addresses the need for intuitive medical devices that can be utilized effectively by a wide range of providers in complex and difficult conflict scenarios that may arise in the future.
The recent contract follows a 2024 partnership between the company and the U.S. Army Institute of Surgical Research, which established a Master Cooperative Research and Development Agreement. This collaborative effort focuses on transforming burn and wound care for military patients. Smith & Nephew states that it maintains a longstanding history of supporting military medical needs, a legacy that began during the First World War. By continuing to innovate its Advanced Wound Management portfolio, the company aims to meet complex clinical requirements while simultaneously helping healthcare providers reduce the negative human and economic consequences associated with severe wounds.
The company operates as a portfolio medical technology business dedicated to the repair, regeneration, and replacement of soft and hard tissue. With its headquarters in Hull, UK, Smith & Nephew reports that it has expanded its footprint to approximately 100 countries and generated $5.8 billion in annual sales during 2024. Through its mission of restoring the self-belief and bodies of patients, the company employs 17,000 individuals globally. Smith & Nephew utilizes its expertise across the specialized business units of Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management to deliver technological advancements to healthcare systems worldwide.
Source
This article summarizes an official Smith & Nephew announcement. Read the original press release at https://www.smith-nephew.com/en/news/2025/05/27/270525-smith-nephew-awarded-contract-to-provide-negative-pressure-wound-therapy. Product availability in Azerbaijan is subject to local registration; contact Azmed Devices for current status.
